Vetter Pharma International GmbH
Is this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Clinical Trial Supply & Logistics
Chemistry, Manufacturing and Controls
Company Overview
About
Vetter Pharma International GmbH is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Neurology
Quick Facts
HQ:Germany
Founded:2017
Employees:2,131
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval EQJH5H
Health Canada · #APR-FKI43EYR · 2018-04-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-K3N9BXW5
Issued: 2020-04-18
Expires: 2025-11-16
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-0E043ZU9
Issued: 2020-12-21
Expires: 2025-08-27
Loading CDMO intelligence...
Key facts about Vetter Pharma International GmbH
- Vetter Pharma International GmbH is headquartered in Germany.
- Vetter Pharma International GmbH was founded in 2017.
- Vetter Pharma International GmbH has 2,131 employees.
- Vetter Pharma International GmbH 's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Vetter Pharma International GmbH
Directory pages this company appears in, each with the full list of matching manufacturers.